Skip to main content
Retour
Watch Compare

VitaNova Life Sciences Corp

Qualité des données : 100%
VNOV
OTC Wholesale Trade Nondurable Goods Wholesale
4,83 €
0,00 € (0,00%)
Cap. Boursière: 40,27 M
Prix
4,83 €
Cap. Boursière
40,27 M
Fourchette du Jour
—
Fourchette 52 Semaines
0,42 € — 7,50 €
Volume
—
Ouverture —
Moyenne 50J / 200J
4,83 €
0,00% above
Moyenne 50J / 200J
3,31 €
45,98% above

Quick Summary

Points Clés

Earnings grew 503,94% over the past year
ROE of 39,74% indicates high profitability
Net margin of 23,34% shows strong profitability
Generating 865 231,0 in free cash flow
P/E of 54,02 — premium valuation
Cash machine — converts 116,06% of earnings into free cash flow

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)366,47%
Earnings (1Y)503,94%
FCF Growth (3Y)N/A

Qualité

Return on Equity
39,74%
Au-dessus de la moyenne du secteur (-3,22%)
ROIC39,79%
Net Margin23,34%
Op. Margin37,44%

Sécurité

Debt / Equity
N/A
Current Ratio5,05
Interest Coverage762,57

Valorisation

PE (TTM)
54,02
Au-dessus de la moyenne du secteur (-0,15)
P/B Ratio21,72
EV/EBITDA33,68
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Wholesale Trade (91 pairs)
Métrique Action Médiane du Secteur
P/E 54,0 -0,2
P/B 21,7 1,0
ROE % 39,7 -3,2
Net Margin % 23,3 -2,4
Rev Growth 5Y % — 2,6
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2026 0,03 €
N/A – N/A
 — —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 366,47% Revenue Growth (3Y) 736,99%
Earnings Growth (1Y) 503,94% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3,19 M Net Income (TTM) 745 479,0
ROE 39,74% ROA 32,08%
Gross Margin 56,46% Operating Margin 37,44%
Net Margin 23,34% Free Cash Flow (TTM) 865 231,0
ROIC 39,79% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5,05
Interest Coverage 762,57 Asset Turnover 1,37
Working Capital 1,85 M Tangible Book Value 1,85 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 54,02 Forward P/E N/A
P/B Ratio 21,72 P/S Ratio 12,61
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 33,68 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 2,15%
Market Cap 40,27 M Enterprise Value 40,27 M
Per Share
EPS (Diluted TTM) 0,02 Revenue / Share 0,38
FCF / Share 0,10 OCF / Share 0,10
EPS CAGR (1Y) 200,00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 116,06%
SBC-Adj. FCF 864 731 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,66 M 570 694,0 38 000,0 120 000,0 0,0
Net Income 850 746,0 140 865,0 -24 227,0 139 682,0 -52 094,0
EPS (Diluted) 0,03 0,01 0,00 0,02 —
Gross Profit 1,58 M 377 711,0 — — —
Operating Income 1,21 M 205 629,0 -24 227,0 -13 367,0 -52 094,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 4 506,0 — — — —
Income Tax 353 558,0 64 869,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,26 M 1,19 M 8 728,0 23 103,0 0,0
Total Liabilities 347 567,0 136 920,0 67 943,0 58 091,0 174 670,0
Shareholders' Equity 1,91 M 1,06 M -59 215,0 -34 988,0 -174 670,0
Total Debt — — — — —
Cash & Equivalents — — 8 728,0 23 103,0 0,0
Current Assets 2,26 M 1,19 M 8 728,0 23 103,0 0,0
Current Liabilities 347 567,0 136 920,0 67 943,0 58 091,0 174 670,0